% | $
Quotes you view appear here for quick access.

Ariad Pharmaceuticals Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • timothyc121855 timothyc121855 Jun 5, 2012 9:57 AM Flag

    Rida's value - Merck comits to moving forward

    Not really part of the ARIA story anymore. Institutional investors have written off Rida after the FDA rejection & poor data. If you think Rida can come back to life somehow please let us know but nobody cares.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • You don't need care. But Merck and Ariad care. As an Ariad true long, I also care.

      "Merck has plans as well to start clinical trials in patients with lung cancer and patients with breast cancer, and potentially other solid tumors. ", said Dr. Berger to Cramer last night.

      • 2 Replies to ariadiiinvestor
      • OK you care--that's great news. Who doesn't care---institutional investors who control the ball here. They have NO EXPECTATIONS for rida & contrary to your comments---or confirmed by Berger with Cramer----ARIA has moved on from rida. MRK can spend their time & effort on it and if successful send a milestone payment to ARIA. PONA is the 100% ARIA controlled product that is the story---at least with the investors who are moving the stock. If that is not clear by now then maybe you need to study up on this one.

      • Ariad..,

        I agree. Tell Carolyn Boone not to care. She had RIDA with stage 4 B.C. - given 3 - 4 months to live. It's been several years now. Look it up on ARIAD's website.

        Merck cares. They still have their agreement She had RIDA and is alive along with many others. That FDA panel of 13 is not the final word as was said at the time. It's on the back burner for ARIAD which still has other constructs in its pipeline going for it.

        GLTU and AL

7.18+0.01(+0.14%)Apr 29 4:00 PMEDT